Levofloxacin Ocular Implant not checked
FollowEvery change as it happens, and a Monday email
Stage
No active trials
Next date
None yet
Trials
0 active
2 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Levofloxacin Ocular Implant an implant that delivers a bolus dose of levofloxacin and a constant daily dose for a further 5-7 days.”In the company’s words, NCT04682288 on ClinicalTrials.gov
- Tested for
- Cataract (2 trials)
- Main trialPhase 1
- “This is a multi center, open label, interventional study in one eye of 5 subjects scheduled for uncomplicated cataract surgery with administration of a single Levofloxacin Ocular Implant in the posterior sulcus of the surgical eye at the end of cataract surgery.”In the company’s words, NCT04682288 on ClinicalTrials.gov
Other drugs for Cataract
- Bimatoprost Implant SystemSpyGlass Pharma, Inc. · Phase 3
- TimoD implantEyeD Pharma · Phase 1/2
- ZOC2017217Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd. · Phase 2
- Eye dropsAce Cells Lab Limited · Marketed (Phase 4 trial)
Coming up0
No dates coming up.
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials2
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 1Completed | 14 Oct 2021 | Levofloxacin Ocular Implant for Ocular Surgery | |
| Phase 1Withdrawn | 15 Dec 2023 | A Study of Levofloxacin Ocular Implant in Patients Undergoing Routine Bilateral Cataract Surgery |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026